The global Remdesivir (COVID-19) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Remdesivir (COVID-19), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Remdesivir (COVID-19).

Report Scope

The Remdesivir (COVID-19) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Remdesivir (COVID-19) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Remdesivir (COVID-19) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Remdesivir (COVID-19) Market Report

Report Metric	Details
Report Name	Remdesivir (COVID-19) Market
CAGR	5%
Segment by Type	5mg 10mg 50mg 100mg
Segment by Application	Hospital Clinics Drug Store Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Borui Bio-Pharmaceutical, Berry Global Group, Inovio Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Remdesivir (COVID-19) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Remdesivir (COVID-19) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Remdesivir (COVID-19) Market report?

Ans: The main players in the Remdesivir (COVID-19) Market are Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Borui Bio-Pharmaceutical, Berry Global Group, Inovio Pharmaceuticals

What are the Application segmentation covered in the Remdesivir (COVID-19) Market report?

Ans: The Applications covered in the Remdesivir (COVID-19) Market report are Hospital, Clinics, Drug Store, Others

What are the Type segmentation covered in the Remdesivir (COVID-19) Market report?

Ans: The Types covered in the Remdesivir (COVID-19) Market report are 5mg, 10mg, 50mg, 100mg

1 Remdesivir (COVID-19) Market Overview

1.1 Product Overview and Scope of Remdesivir (COVID-19)

1.2 Remdesivir (COVID-19) Segment by Type

1.2.1 Global Remdesivir (COVID-19) Market Value Comparison by Type (2024-2030)

1.2.2 5mg

1.2.3 10mg

1.2.4 50mg

1.2.5 100mg

1.3 Remdesivir (COVID-19) Segment by Application

1.3.1 Global Remdesivir (COVID-19) Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Drug Store

1.3.5 Others

1.4 Global Remdesivir (COVID-19) Market Size Estimates and Forecasts

1.4.1 Global Remdesivir (COVID-19) Revenue 2019-2030

1.4.2 Global Remdesivir (COVID-19) Sales 2019-2030

1.4.3 Global Remdesivir (COVID-19) Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Remdesivir (COVID-19) Market Competition by Manufacturers

2.1 Global Remdesivir (COVID-19) Sales Market Share by Manufacturers (2019-2024)

2.2 Global Remdesivir (COVID-19) Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Remdesivir (COVID-19) Average Price by Manufacturers (2019-2024)

2.4 Global Remdesivir (COVID-19) Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Remdesivir (COVID-19), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Remdesivir (COVID-19), Product Type & Application

2.7 Remdesivir (COVID-19) Market Competitive Situation and Trends

2.7.1 Remdesivir (COVID-19) Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Remdesivir (COVID-19) Players Market Share by Revenue

2.7.3 Global Remdesivir (COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Remdesivir (COVID-19) Retrospective Market Scenario by Region

3.1 Global Remdesivir (COVID-19) Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Remdesivir (COVID-19) Global Remdesivir (COVID-19) Sales by Region: 2019-2030

3.2.1 Global Remdesivir (COVID-19) Sales by Region: 2019-2024

3.2.2 Global Remdesivir (COVID-19) Sales by Region: 2025-2030

3.3 Global Remdesivir (COVID-19) Global Remdesivir (COVID-19) Revenue by Region: 2019-2030

3.3.1 Global Remdesivir (COVID-19) Revenue by Region: 2019-2024

3.3.2 Global Remdesivir (COVID-19) Revenue by Region: 2025-2030

3.4 North America Remdesivir (COVID-19) Market Facts & Figures by Country

3.4.1 North America Remdesivir (COVID-19) Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Remdesivir (COVID-19) Sales by Country (2019-2030)

3.4.3 North America Remdesivir (COVID-19) Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Remdesivir (COVID-19) Market Facts & Figures by Country

3.5.1 Europe Remdesivir (COVID-19) Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Remdesivir (COVID-19) Sales by Country (2019-2030)

3.5.3 Europe Remdesivir (COVID-19) Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Remdesivir (COVID-19) Market Facts & Figures by Country

3.6.1 Asia Pacific Remdesivir (COVID-19) Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Remdesivir (COVID-19) Sales by Country (2019-2030)

3.6.3 Asia Pacific Remdesivir (COVID-19) Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Remdesivir (COVID-19) Market Facts & Figures by Country

3.7.1 Latin America Remdesivir (COVID-19) Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Remdesivir (COVID-19) Sales by Country (2019-2030)

3.7.3 Latin America Remdesivir (COVID-19) Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Remdesivir (COVID-19) Market Facts & Figures by Country

3.8.1 Middle East and Africa Remdesivir (COVID-19) Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Remdesivir (COVID-19) Sales by Country (2019-2030)

3.8.3 Middle East and Africa Remdesivir (COVID-19) Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Remdesivir (COVID-19) Sales by Type (2019-2030)

4.1.1 Global Remdesivir (COVID-19) Sales by Type (2019-2024)

4.1.2 Global Remdesivir (COVID-19) Sales by Type (2025-2030)

4.1.3 Global Remdesivir (COVID-19) Sales Market Share by Type (2019-2030)

4.2 Global Remdesivir (COVID-19) Revenue by Type (2019-2030)

4.2.1 Global Remdesivir (COVID-19) Revenue by Type (2019-2024)

4.2.2 Global Remdesivir (COVID-19) Revenue by Type (2025-2030)

4.2.3 Global Remdesivir (COVID-19) Revenue Market Share by Type (2019-2030)

4.3 Global Remdesivir (COVID-19) Price by Type (2019-2030)

5 Segment by Application

5.1 Global Remdesivir (COVID-19) Sales by Application (2019-2030)

5.1.1 Global Remdesivir (COVID-19) Sales by Application (2019-2024)

5.1.2 Global Remdesivir (COVID-19) Sales by Application (2025-2030)

5.1.3 Global Remdesivir (COVID-19) Sales Market Share by Application (2019-2030)

5.2 Global Remdesivir (COVID-19) Revenue by Application (2019-2030)

5.2.1 Global Remdesivir (COVID-19) Revenue by Application (2019-2024)

5.2.2 Global Remdesivir (COVID-19) Revenue by Application (2025-2030)

5.2.3 Global Remdesivir (COVID-19) Revenue Market Share by Application (2019-2030)

5.3 Global Remdesivir (COVID-19) Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Gilead Sciences

6.1.1 Gilead Sciences Corporation Information

6.1.2 Gilead Sciences Description and Business Overview

6.1.3 Gilead Sciences Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Gilead Sciences Remdesivir (COVID-19) Product Portfolio

6.1.5 Gilead Sciences Recent Developments/Updates

6.2 Bright Gene

6.2.1 Bright Gene Corporation Information

6.2.2 Bright Gene Description and Business Overview

6.2.3 Bright Gene Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Bright Gene Remdesivir (COVID-19) Product Portfolio

6.2.5 Bright Gene Recent Developments/Updates

6.3 Hainan Haiyao

6.3.1 Hainan Haiyao Corporation Information

6.3.2 Hainan Haiyao Description and Business Overview

6.3.3 Hainan Haiyao Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Hainan Haiyao Remdesivir (COVID-19) Product Portfolio

6.3.5 Hainan Haiyao Recent Developments/Updates

6.4 Kelun Pharma

6.4.1 Kelun Pharma Corporation Information

6.4.2 Kelun Pharma Description and Business Overview

6.4.3 Kelun Pharma Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Kelun Pharma Remdesivir (COVID-19) Product Portfolio

6.4.5 Kelun Pharma Recent Developments/Updates

6.5 Hunan Warrant Pharmaceutical

6.5.1 Hunan Warrant Pharmaceutical Corporation Information

6.5.2 Hunan Warrant Pharmaceutical Description and Business Overview

6.5.3 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product Portfolio

6.5.5 Hunan Warrant Pharmaceutical Recent Developments/Updates

6.6 Borui Bio-Pharmaceutical

6.6.1 Borui Bio-Pharmaceutical Corporation Information

6.6.2 Borui Bio-Pharmaceutical Description and Business Overview

6.6.3 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product Portfolio

6.6.5 Borui Bio-Pharmaceutical Recent Developments/Updates

6.7 Berry Global Group

6.6.1 Berry Global Group Corporation Information

6.6.2 Berry Global Group Description and Business Overview

6.6.3 Berry Global Group Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Berry Global Group Remdesivir (COVID-19) Product Portfolio

6.7.5 Berry Global Group Recent Developments/Updates

6.8 Inovio Pharmaceuticals

6.8.1 Inovio Pharmaceuticals Corporation Information

6.8.2 Inovio Pharmaceuticals Description and Business Overview

6.8.3 Inovio Pharmaceuticals Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Inovio Pharmaceuticals Remdesivir (COVID-19) Product Portfolio

6.8.5 Inovio Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Remdesivir (COVID-19) Industry Chain Analysis

7.2 Remdesivir (COVID-19) Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Remdesivir (COVID-19) Production Mode & Process

7.4 Remdesivir (COVID-19) Sales and Marketing

7.4.1 Remdesivir (COVID-19) Sales Channels

7.4.2 Remdesivir (COVID-19) Distributors

7.5 Remdesivir (COVID-19) Customers

8 Remdesivir (COVID-19) Market Dynamics

8.1 Remdesivir (COVID-19) Industry Trends

8.2 Remdesivir (COVID-19) Market Drivers

8.3 Remdesivir (COVID-19) Market Challenges

8.4 Remdesivir (COVID-19) Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Hunan Warrant Pharmaceutical

Borui Bio-Pharmaceutical

Berry Global Group

Inovio Pharmaceuticals

List of Tables

Table 1. Global Remdesivir (COVID-19) Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Remdesivir (COVID-19) Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Remdesivir (COVID-19) Market Competitive Situation by Manufacturers in 2023

Table 4. Global Remdesivir (COVID-19) Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Remdesivir (COVID-19) Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Remdesivir (COVID-19) Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Remdesivir (COVID-19) Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Remdesivir (COVID-19) Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Remdesivir (COVID-19), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Remdesivir (COVID-19), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Remdesivir (COVID-19), Product Type & Application

Table 12. Global Key Manufacturers of Remdesivir (COVID-19), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Remdesivir (COVID-19) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Remdesivir (COVID-19) as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Remdesivir (COVID-19) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Remdesivir (COVID-19) Sales by Region (2019-2024) & (K Units)

Table 18. Global Remdesivir (COVID-19) Sales Market Share by Region (2019-2024)

Table 19. Global Remdesivir (COVID-19) Sales by Region (2025-2030) & (K Units)

Table 20. Global Remdesivir (COVID-19) Sales Market Share by Region (2025-2030)

Table 21. Global Remdesivir (COVID-19) Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Remdesivir (COVID-19) Revenue Market Share by Region (2019-2024)

Table 23. Global Remdesivir (COVID-19) Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Remdesivir (COVID-19) Revenue Market Share by Region (2025-2030)

Table 25. North America Remdesivir (COVID-19) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Remdesivir (COVID-19) Sales by Country (2019-2024) & (K Units)

Table 27. North America Remdesivir (COVID-19) Sales by Country (2025-2030) & (K Units)

Table 28. North America Remdesivir (COVID-19) Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Remdesivir (COVID-19) Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Remdesivir (COVID-19) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Remdesivir (COVID-19) Sales by Country (2019-2024) & (K Units)

Table 32. Europe Remdesivir (COVID-19) Sales by Country (2025-2030) & (K Units)

Table 33. Europe Remdesivir (COVID-19) Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Remdesivir (COVID-19) Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Remdesivir (COVID-19) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Remdesivir (COVID-19) Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Remdesivir (COVID-19) Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Remdesivir (COVID-19) Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Remdesivir (COVID-19) Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Remdesivir (COVID-19) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Remdesivir (COVID-19) Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Remdesivir (COVID-19) Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Remdesivir (COVID-19) Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Remdesivir (COVID-19) Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Remdesivir (COVID-19) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Remdesivir (COVID-19) Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Remdesivir (COVID-19) Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Remdesivir (COVID-19) Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Remdesivir (COVID-19) Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Remdesivir (COVID-19) Sales (K Units) by Type (2019-2024)

Table 51. Global Remdesivir (COVID-19) Sales (K Units) by Type (2025-2030)

Table 52. Global Remdesivir (COVID-19) Sales Market Share by Type (2019-2024)

Table 53. Global Remdesivir (COVID-19) Sales Market Share by Type (2025-2030)

Table 54. Global Remdesivir (COVID-19) Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Remdesivir (COVID-19) Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Remdesivir (COVID-19) Revenue Market Share by Type (2019-2024)

Table 57. Global Remdesivir (COVID-19) Revenue Market Share by Type (2025-2030)

Table 58. Global Remdesivir (COVID-19) Price (US$/Unit) by Type (2019-2024)

Table 59. Global Remdesivir (COVID-19) Price (US$/Unit) by Type (2025-2030)

Table 60. Global Remdesivir (COVID-19) Sales (K Units) by Application (2019-2024)

Table 61. Global Remdesivir (COVID-19) Sales (K Units) by Application (2025-2030)

Table 62. Global Remdesivir (COVID-19) Sales Market Share by Application (2019-2024)

Table 63. Global Remdesivir (COVID-19) Sales Market Share by Application (2025-2030)

Table 64. Global Remdesivir (COVID-19) Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Remdesivir (COVID-19) Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Remdesivir (COVID-19) Revenue Market Share by Application (2019-2024)

Table 67. Global Remdesivir (COVID-19) Revenue Market Share by Application (2025-2030)

Table 68. Global Remdesivir (COVID-19) Price (US$/Unit) by Application (2019-2024)

Table 69. Global Remdesivir (COVID-19) Price (US$/Unit) by Application (2025-2030)

Table 70. Gilead Sciences Corporation Information

Table 71. Gilead Sciences Description and Business Overview

Table 72. Gilead Sciences Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Gilead Sciences Remdesivir (COVID-19) Product

Table 74. Gilead Sciences Recent Developments/Updates

Table 75. Bright Gene Corporation Information

Table 76. Bright Gene Description and Business Overview

Table 77. Bright Gene Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Bright Gene Remdesivir (COVID-19) Product

Table 79. Bright Gene Recent Developments/Updates

Table 80. Hainan Haiyao Corporation Information

Table 81. Hainan Haiyao Description and Business Overview

Table 82. Hainan Haiyao Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Hainan Haiyao Remdesivir (COVID-19) Product

Table 84. Hainan Haiyao Recent Developments/Updates

Table 85. Kelun Pharma Corporation Information

Table 86. Kelun Pharma Description and Business Overview

Table 87. Kelun Pharma Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Kelun Pharma Remdesivir (COVID-19) Product

Table 89. Kelun Pharma Recent Developments/Updates

Table 90. Hunan Warrant Pharmaceutical Corporation Information

Table 91. Hunan Warrant Pharmaceutical Description and Business Overview

Table 92. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product

Table 94. Hunan Warrant Pharmaceutical Recent Developments/Updates

Table 95. Borui Bio-Pharmaceutical Corporation Information

Table 96. Borui Bio-Pharmaceutical Description and Business Overview

Table 97. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product

Table 99. Borui Bio-Pharmaceutical Recent Developments/Updates

Table 100. Berry Global Group Corporation Information

Table 101. Berry Global Group Description and Business Overview

Table 102. Berry Global Group Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Berry Global Group Remdesivir (COVID-19) Product

Table 104. Berry Global Group Recent Developments/Updates

Table 105. Inovio Pharmaceuticals Corporation Information

Table 106. Inovio Pharmaceuticals Description and Business Overview

Table 107. Inovio Pharmaceuticals Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Inovio Pharmaceuticals Remdesivir (COVID-19) Product

Table 109. Inovio Pharmaceuticals Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Remdesivir (COVID-19) Distributors List

Table 113. Remdesivir (COVID-19) Customers List

Table 114. Remdesivir (COVID-19) Market Trends

Table 115. Remdesivir (COVID-19) Market Drivers

Table 116. Remdesivir (COVID-19) Market Challenges

Table 117. Remdesivir (COVID-19) Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Remdesivir (COVID-19)

Figure 2. Global Remdesivir (COVID-19) Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Remdesivir (COVID-19) Market Share by Type in 2023 & 2030

Figure 4. 5mg Product Picture

Figure 5. 10mg Product Picture

Figure 6. 50mg Product Picture

Figure 7. 100mg Product Picture

Figure 8. Global Remdesivir (COVID-19) Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Remdesivir (COVID-19) Market Share by Application in 2023 & 2030

Figure 10. Hospital

Figure 11. Clinics

Figure 12. Drug Store

Figure 13. Others

Figure 14. Global Remdesivir (COVID-19) Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Remdesivir (COVID-19) Market Size (2019-2030) & (US$ Million)

Figure 16. Global Remdesivir (COVID-19) Sales (2019-2030) & (K Units)

Figure 17. Global Remdesivir (COVID-19) Average Price (US$/Unit) & (2019-2030)

Figure 18. Remdesivir (COVID-19) Report Years Considered

Figure 19. Remdesivir (COVID-19) Sales Share by Manufacturers in 2023

Figure 20. Global Remdesivir (COVID-19) Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Remdesivir (COVID-19) Players: Market Share by Revenue in 2023

Figure 22. Remdesivir (COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Remdesivir (COVID-19) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Remdesivir (COVID-19) Sales Market Share by Country (2019-2030)

Figure 25. North America Remdesivir (COVID-19) Revenue Market Share by Country (2019-2030)

Figure 26. U.S. Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Remdesivir (COVID-19) Sales Market Share by Country (2019-2030)

Figure 29. Europe Remdesivir (COVID-19) Revenue Market Share by Country (2019-2030)

Figure 30. Germany Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Remdesivir (COVID-19) Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Remdesivir (COVID-19) Revenue Market Share by Region (2019-2030)

Figure 37. China Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Taiwan Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Indonesia Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Thailand Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Malaysia Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Philippines Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America Remdesivir (COVID-19) Sales Market Share by Country (2019-2030)

Figure 48. Latin America Remdesivir (COVID-19) Revenue Market Share by Country (2019-2030)

Figure 49. Mexico Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Remdesivir (COVID-19) Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa Remdesivir (COVID-19) Revenue Market Share by Country (2019-2030)

Figure 54. Turkey Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. UAE Remdesivir (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of Remdesivir (COVID-19) by Type (2019-2030)

Figure 58. Global Revenue Market Share of Remdesivir (COVID-19) by Type (2019-2030)

Figure 59. Global Remdesivir (COVID-19) Price (US$/Unit) by Type (2019-2030)

Figure 60. Global Sales Market Share of Remdesivir (COVID-19) by Application (2019-2030)

Figure 61. Global Revenue Market Share of Remdesivir (COVID-19) by Application (2019-2030)

Figure 62. Global Remdesivir (COVID-19) Price (US$/Unit) by Application (2019-2030)

Figure 63. Remdesivir (COVID-19) Value Chain

Figure 64. Remdesivir (COVID-19) Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-39G3887

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

Over the Counter (OTC) & Diet Supplementary - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-17I13362

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

TNF & IL Cytokines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-1A8821

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Pregabalin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-21O7531

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Remdesivir (COVID-19) Market Research Report 2024

Published Date: June 2024

Report Code: QYRE-Auto-3X8392

Global Remdesivir (COVID-19) Market Research Report 2024

FEATURED COMPANIES

Remdesivir (COVID-19) Market Size

Remdesivir (COVID-19) Market

Report Scope

Scope of Remdesivir (COVID-19) Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Remdesivir (COVID-19) Market report?

What are the Application segmentation covered in the Remdesivir (COVID-19) Market report?

What are the Type segmentation covered in the Remdesivir (COVID-19) Market report?

FEATURED COMPANIES

RELATED REPORTS